Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

New treatment improves male hair loss.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Mushrooms have beneficial properties for skin and hair care products and have great potential for future cosmetic use.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Semecarpus anacardium Linn. has many medicinal benefits.

Both mouse and rat models are effective for testing alopecia areata treatments.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Effective treatments for severe alopecia areata are still lacking.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

A substance from a specific gel helped to grow hair effectively in mice, suggesting it could potentially be used to treat hair loss in humans.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.